Abstract:The phosphatidylinositol 3' –kinase (PI3K)-Akt signaling pathway has been shown to be critical in modulating platelet function and increasing number of studies have been focusing on the development of PI3K inhibitors to modulate platelet function. We recently identified a novel small molecule compound S14161, namely 8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene, displaying potent antileukemia and antimyeloma activity via inhibition of the PI3K pathway (Mao et al, Blood, 2011, 117:1986). In the present study, we evaluated the effect of S14161 on platelet activation and the underlying mechanisms. Gel-filtered human platelets were isolated from venous blood of healthy adults and the effect of S14161 on platelet aggregation in response to agonists was determined. Results showed that S14161 inhibited platelet aggregation induced by collagen, convulxin, thrombin, PAR1 agonist peptide SFLLRN, and U46619 in a dose dependent manner (2.5-10μM) with the most striking inhibition for collagen by 89.8% (P<0.001, n=3) and for U46619 by 94.3% (P<0.001, n=3), respectively compared to vehicle-treated samples when 10μM S14161 was used. Flow cytometry studies showed that S14161 inhibits convulxin- or thrombin-induced P-selectin expression and fibrinogen binding of single platelet. S14161 also inhibited platelet spreading on fibrinogen and clot retraction, processes mediated by outside-in signaling. Using a microfluidic chamber we demonstrated that incubation of S14161 decreases platelet adhesion on collagen-coated surface by about 80% at various time points of blood flow in the chambers. Western blot showed that similar to LY294002, the classic PI3K inhibitor, S14161 inhibited phosphorylation of Akt Ser473 and Akt Thr308 in response to collagen, thrombin, or U46619, implying the involvement of PI3K pathway. Additionally, S14161 inhibited MAPK/ERK1/2 phosphorylation. Finally, the effects of S14161 on thrombus formation in vivo were measured using a ferric chloride-induced carotid artery injury model in mice. The intraperitoneal injection of S14161 (2mg/kg) to male C57BL6/J mice significantly extended the first occlusion time (5.05±0.99 min, N=9) compared to the vehicle controls (3.72±0.95 min, N=8) (P<0.05), but did not increase the bleeding time (P>0.05). Taken together, our data showed that S14161 inhibits platelet activation and thrombus formation, and may be developed as a novel therapeutic agent for the prevention of thrombotic disorders. (This study was supported by National Natural Science Foundation of China 81170132 to Li Zhu)

Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation

Modulation Of Platelet Activation And Thrombus Formation Using A Pan-Pi3k Inhibitor S14161

Targeting the Pi3k/Akt Pathway to Inhibit Platelet Activation and Thrombus Formation

Abstract 56: S14161 Inhibits Platelet Activation and Thrombus Formation Via PI3K Signaling Pathway

Targeting Thymidine Phosphorylase With Tipiracil Hydrochloride Attenuates Thrombosis Without Increasing Risk of Bleeding in Mice

Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling

Pharmacological Inhibition of S6K1 Facilitates Platelet Activation by Enhancing Akt Phosphorylation

The Pyrrolidinoindoline Alkaloid Psm2 Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling

Platelet-Specific P38α Deficiency Improved Cardiac Function after Myocardial Infarction in Mice

The inhibitory effect of tachyplesin I on thrombosis and its mechanisms

Lim Kinase-1 Selectively Promotes Glycoprotein Ib-Ix-Mediated Txa(2) Synthesis, Platelet Activation, And Thrombosis

Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function

The Antithrombotic Agent Pterostilbene Interferes with Integrin αIIbβ3-Mediated Inside-Out and Outside-In Signals in Human Platelets

Sphingosine 1-Phosphate Produced By Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro And In Vivo

Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report

Prolonged Inhibition of Protein Kinase A Results in Metalloproteinase-Dependent Platelet Gpib Alpha Shedding

Ginkgetin effectively mitigates collagen and AA‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human

New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.

Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy

Asebogenin Suppresses Thrombus Formation Via Inhibition of Syk Phosphorylation.

Protein Kinase C–catalyzed Phosphorylation of an Inhibitory Phosphoprotein of Myosin Phosphatase is Involved in Human Platelet Secretion